Dicyclic and Tricyclic Diaminopyrimidine Derivatives as Potent Inhibitors of Cryptosporidium parvum Dihydrofolate Reductase: Structure-Activity and Structure-Selectivity Correlations
Authors:
- R. G. NelsonRNR. G. Nelson
- A. RosowskyARA. Rosowsky
- Axel DalhoffADAxel Dalhoff
- Andrej WeintraubAWAndrej Weintraub
- 1 March 2002
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (3) , 940
Abstract
The proof that a new antibacterial agent is not only active in vitro but also effective in vivo under clinically relevant conditions is currently provided (i) by using appropriate nonclinical models of infection and pharmacokinetic-pharmacodynamic (PK-PD) analysis providing evidence of the likelihood of clinical efficacy and (ii) by examining the study drug in exploratory clinical trials, as well as dose and schedule finding during phase II of clinical development. This approach is both time-consuming and costly. Furthermore, PK-PD targets for any novel antibacterial agent cannot be derived from studies with experimental animals. Therefore, alternative strategies have to be identified to prove the principle that a novel antibacterial agent is active under clinically relevant conditions. This review summarizes evidence that the quantitative analysis of shifts in the viable counts of pathogens in infected patients or the evaluation of the PD effect of an investigational agent on indicator organisms of the human resident microflora or colonizers of healthy volunteers, if paralleled with PK monitoring of serum and the target site, provides an alternative to a classical proof-of-principle study in the course of a phase II study program.Keywords
This publication has 62 references indexed in Scilit:
- Comparative In Vitro Activities of AC98-6446, a Novel Semisynthetic Glycopeptide Derivative of the Natural Product Mannopeptimycin α, and Other Antimicrobial Agents against Gram-Positive Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2004
- Antimicrobial Activities of BMS-284756 Compared with Those of Fluoroquinolones and β-Lactams against Gram-Positive Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2002
- Determinants of Staphylococcus aureus Nasal CarriageClinical and Diagnostic Laboratory Immunology, 2001
- Effect of antimicrobial agents on the ecological balance of human microfloraThe Lancet Infectious Diseases, 2001
- Nationwide German Multicenter Study on the Prevalence of Antibiotic Resistance in Streptococcal Blood Isolates from Neutropenic Patients and Comparative In Vitro Activities of Quinupristin-Dalfopristin and Eight Other AntimicrobialsJournal of Clinical Microbiology, 2001
- Effect of Quinolones against Slowly Growing BacteriaChemotherapy, 1995
- Correlation between pharmacokinetics, pharmacodynamics and efficacy of antibacterial agents in animal modelsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Comparison of the Invesligalional drug, LV146032, with vancomycin in experimental pneumonia due to methidillln-resistant Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1988
- Gentamicin Inactivation in Purulent Exudates: Role of Cell LysisThe Journal of Infectious Diseases, 1980
- In-Vitro Activity of Carbenicillin and Results of Treatment of Infections due to Pseudomonas with Carbenicillin Singly and in Combination with GentamicinThe Journal of Infectious Diseases, 1970